Bone Disease in Thalassemia: A Frequent and Still Unresolved Problem

Abstract

Adults with β thalassemia major frequently have low BMD, fractures, and bone pain. The purpose of this study was to determine the prevalence of low BMD, fractures, and bone pain in all thalassemia syndromes in childhood, adolescence, and adulthood, associations of BMD with fractures and bone pain, and etiology of bone disease in thalassemia. Patients of all thalassemia syndromes in the Thalassemia Clinical Research Network, ≥6 yr of age, with no preexisting medical condition affecting bone mass or requiring steroids, participated. We measured spine and femur BMD and whole body BMC by DXA and assessed vertebral abnormalities by morphometric X-ray absorptiometry (MXA). Medical history by interview and review of medical records, physical examinations, and blood and urine collections were performed. Three hundred sixty-one subjects, 49% male, with a mean age of 23.2 yr (range, 6.1–75 yr), were studied. Spine and femur BMD Z-scores < −2 occurred in 46% and 25% of participants, respectively. Greater age, lower weight, hypogonadism, and increased bone turnover were strong independent predictors of low bone mass regardless of thalassemia syndrome. Peak bone mass was suboptimal. Thirty-six percent of patients had a history of fractures, and 34% reported bone pain. BMD was negatively associated with fractures but not with bone pain. Nine percent of participants had uniformly decreased height of several vertebrae by MXA, which was associated with the use of iron chelator deferoxamine before 6 yr of age. In patients with thalassemia, low BMD and fractures occur frequently and independently of the particular syndrome. Peak bone mass is suboptimal. Low BMD is associated with hypogonadism, increased bone turnover, and an increased risk for fractures.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 39

1. 1.

   Weatherall DJ. Phenotype-genotype relationship in monogenic disease: Lessons from the thalassemias. Nat Rev. 2001;2:245-255.

   Not in our library10.1038/35066048

2. 2.

   Calleja E, Shen JY, Lesser M, Grady RW, New MI, Giardina PJ. Survival and Morbidity in Transfusion Dependent Thalassemia Patients on Subcutaneous Desferrioxamine Chelation: Nearly Two Decades of Experience. NY Acad Sci. 1998;850:469-470.

   Not in our library10.1111/j.1749-6632.1998.tb10524.x

3. 3.

   Ehlers KH, Giardina PJ, Lesser ML, Engle MA, Hilgartner MW. Prolonged survival in patients with beta-thalassemia major treated with deferoxamine. J Pediatr. 1991;118:540-545.

   Not in our library10.1016/s0022-3476(05)83374-8

4. 4.

   Cooley TB, Lee P. A series of cases of splenomegaly in children with anemia and peculiar bone changes. Trans Am Pediatr Soc. 1925;37:29-30.

   Not in our library

5. 5.

   Wolman IJ, Ortalani M. Some clinical features of Cooley's anemia patients as related to transfusion schedules. Ann NY Acad Sci. 1969;105:407.

   Not in our library10.1111/j.1749-6632.1969.tb27811.x

6. 6.

   Piomelli S. The management of patients with Cooley's anemia: Transfusions and splenectomy. Sem Hematol. 1995;32:262-268.

   Not in our library

7. 7.

   Jensen CE, Tuck SM, Agnew JE, Koneru S, Morris RW, Yardumian A, Prescott E, Hoffbrand AV, Wonke B. High incidence of osteoporosis in Thalassemia major. J Pediatr Endocrinol Metab. 1998;11(Suppl 3):975-977.

   Not in our library

8. 8.

   Giardina PJ, Schneider R, Lesser M, Simmons B, Rodriguez A, Gertner J, New M, Hilgartner MW. Abnormal Bone Metabolism in Thalassemia. Endocrine Disorders in Thalassemia. 1995.

   Not in our library

9. 9.

   Origa R, Fiumana E, Gamberini MR, Armari S, Mottes M, Sangalli A, Paglietti E, Galanello R, Borgna-Pignatti C. Osteoporosis I β-thalassemia: Clinical and genetic aspects. NY Acad Sci. 2005;1054:451-456.

   Not in our library10.1196/annals.1345.051

10. 10.

    Dresner Pollack R, Rachmilewitz E, Blumenfeld A, Idelson M, Goldfarb AW. Bone mineral metabolism in adults with β-thalassemia major and intermedia. Br J Haematol. 2000;111:902-907.

    Not in our library

11. 11.

    Carmina E, Di Fede G, Napoli N, Renda G, Vitale G, Lo Pinto C, Bruno D, Malizia R, Rini GB. Hypogonadism and hormone replacement therapy on bone mass of adult women with Thalassemia major. Calcif Tissue Int. 2004;74:68-71.

    Not in our library10.1007/s00223-002-1044-3

12. 12.

    DiStefano M, Chiabotto P, Roggia C, Garofalo F, Lala R, Piga A, Isaia GC. Bone mass and metabolism in thalassemic children and adolescents with different iron cheating drugs. J Bone Miner Metab. 2004;22:53-57.

    Not in our library10.1007/s00774-003-0449-z

13. 13.

    Leung TF, Hung ECW, Lam CWK, Li CK, Chu Y, Chik KW, Shing MMK, Lee V, Yuen PMP. Bone mineral density in children with thalassemia major: Determining factors and effects of bone marrow transplantation. Bone Marrow Transplant. 2005;36:331-336.

    Not in our library10.1038/sj.bmt.1705053

14. 14.

    Mahachoklertwattana P, Pootrakul P, Chuansumrit A, Choubtum L, Sriphrapradang A, Sirisriro R, Rajatanavin R. Association between bone mineral density and erythropoiesis in Thai achildren and adolescents with thalassemia syndromes. J Bone Miner Metab. 2006;24:146-152.

    Not in our library10.1007/s00774-005-0661-0

15. 15.

    Perrotta S, Cappellini MD, Bertoldo F, Servedio V, Iolascon G, D'Agruma L, Gasparini P, Siciliani MC, Iolascon A. Osteoporosis in β-thalassemia major patients: Analysis of the genetic background. Br J Haematol. 2000;111:461-466.

    Not in our library10.1046/j.1365-2141.2000.02382.x

16. 16.

    Lasco A, Morabito N, Gaudio A, Buemi M, Wasniewska M, Frisina N. Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major. Osteoporos Int. 2001;12:570-575.

    Not in our library10.1007/s001980170079

17. 17.

    Bielinski BK, Darbyshire PJ, Mathers L, Crabtree NJ, Kirk JMW, Stirling HF, Shaw NJ. Impact of disordered puberty on bone density in beta-thalassemia major. Br J Haematol. 2003;120:353-358.

    Not in our library10.1046/j.1365-2141.2003.04066.x

18. 18.

    Greulich WW, Pyle SI. Radiographic Atlas of Skeletal Development of the Hand and Wrist. 1959.

    Not in our library

19. 19.

    Genant HK, Wu CY, Van Kuijk C, Nevitt M. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137-1148.

    Not in our library10.1002/jbmr.5650080915

20. 20.

    Hastie T, Tibshirani R. Generalized Additive Models. 1990.

    Not in our library10.1177/096228029500400302

21. 21.

    Efron B, Tibshirani RJ. An Introduction to the Bootstrap. 1993.

    Not in our library

22. 22.

    Lin DY, Wei LJ, Yang I, Ying Z. Semiparametric regression for the mean and rate functions of recurrent events. J R Stat Soc B. 2000;62:711-730.

    Not in our library

23. 23.

    Salama OS, Al-Tonbary YA, Shahin RA, Eldeen OA. Unbalanced bone turnover in children with beta thalassemia. Hematology (Am Soc Hematol Educ Program). 2006;11:197-202.

    Not in our library10.1080/10245330600702851

24. 24.

    Angelopoulos NG, Goula A, Katounda E, Rombopoulos G, Kaltsidou V, Kaltsas D, Mulaktari S, Athanasiadou V, Tolis G. Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system in patients with beta-thalassemia major. J Bone Miner Metab. 2007;25:60-67.

    Not in our library10.1007/s00774-006-0728-6

25. 25.

    Gambacciani M, Monteleone P, Ciaponi M, Sacco A, Genazzani AR. Effects of oral contraceptives on bone mineral density. Treat Endocrinol. 2004;2:191-196.

    Not in our library10.2165/00024677-200403030-00006

26. 26.

    Mundy GR. Osteoporosis and inflammation. Nutr Rev. 2007;65:S147-S151.

    Not in our library10.1111/j.1753-4887.2007.tb00353.x

27. 27.

    Grassi F, Tell G, Robbie-Ryan M, Gao Y, Terauchi M, Yang X, Romanello M, Jones DP, Weitzmann MN, Pacifici R. Oxidative stress causes bone loss in estrogen-deficient mice through enhanced bone marrow dendritic cell activation. Proc Natl Acad Sci USA. 2007;104:15087-15092.

    Not in our library10.1073/pnas.0703610104

28. 28.

    Cighetti G, Duca L, Bortone L, Sala S, Nava I, Fiorelli G, Cappellini MD. Oxidative status and malondialdehyde in β-thalassemia patients. Eur J Clin Invest. 2002;32(Supp 1):β55-60.

    Not in our library10.1046/j.1365-2362.2002.0320s1055.x

29. 29.

    Anapliotou MLG, Kastanias IT, Psara P, Evangelou EA, Lipiraki M, Dimitriou P. The contribution of hypogonadism to the development of osteoporosis in thalassemia major: New therapeutic approaches. Clin Endocrinol (Oxf). 1995;42:279-287.

    Not in our library10.1111/j.1365-2265.1995.tb01876.x

30. 30.

    Molyvda-Athanasopoulou E, Sioundas A, Karatzas N, Aggellaki M, Pazaitou K, Vainas I. Bone mineral density of patients with thalassemia major. Calcif Tissue Int. 1999;64:481-484.

    Not in our library10.1007/s002239900637

31. 31.

    Lasco A, Morabito N, Gaudio A, Buemi M, Wasniewska M, Frisina N. Effects of hormonal replacement therapy on bone metabolism in young adults with beta-thalassemia major. Osteoporos Int. 2001;12:570-575.

    Not in our library10.1007/s001980170079

32. 32.

    Napoli N, Carmina E, Bucchieri S, Sferrazza C, Rini GB, Di Fede G. Low serum levels of 25-hydroxyvitamin D in adults affected by thalassemia major or intermedia. Bone. 2006;38:888-892.

    Not in our library10.1016/j.bone.2005.11.018

33. 33.

    Domrongkitchaiporn S, Sirikulchayanonta V, Angchaisuksiri P, Stitchantrakul W, Kanokkantopong C, Rajatanavin R. Abnormalities in bone mineral density and bone histology in thalassemia. J Bone Miner Res. 2003;18:1682-1686.

    Not in our library10.1359/jbmr.2003.18.9.1682

34. 34.

    Dines DM, Canale VC, Arnold WD. Fractures in thalassemia. J Bone Joint Surg Am. 1976;58:662-666.

    Not in our library

35. 35.

    Vogiatzi MG, Macklin EA, Fung EB, Vichinsky E, Olivieri N, Kwiatkowski J, Cohen A, Neufeld E, Giardina PJ. Prevalence of fractures among the thalassemia syndromes in North America. Bone. 2006;38:571-575.

    Not in our library10.1016/j.bone.2005.10.001

36. 36.

    Johansen A, Evans RJ, Stone MD, Richmond PW, Lo SV, Woodhouse KW. Fracture Incidence in England and Whales: A study based on population of Cardiff. Injury. 1997;28:655-660.

    Not in our library10.1016/s0020-1383(97)00144-7

37. 37.

    Jones IE, Williams SM, Dow N, Goulding A. How many children remain fracture free during growth? A longitudinal study of children and adolescents participating in the Dunedin Multidisciplinary Health and development study. Osteoporos Int. 2002;13:990-995.

    Not in our library10.1007/s001980200137

38. 38.

    Melton LJ, Kan SH, Frye MA, Wahner HW, O'Fallon WM, Riggs BL. Epidemiology of vertebral fractures in women. Am J Epidemiol. 1989;129:1000-1011.

    Not in our library10.1093/oxfordjournals.aje.a115204

39. 39.

    Brill PW, Winchester P, Giardina PJ, Cunningham-Rundles S. Desferoxamine-induced bone dysplasia in patients with thalassemia major. Am J Radiol. 1991;156:561-565.

    Not in our library10.2214/ajr.156.3.1899759

Cited by papers we hold 3

• Influence of Iron on Bone Homeostasis · 2018
  No notice
• Clinical Impact and Cellular Mechanisms of Iron Overload-Associated Bone Loss · 2017
  No notice
• Chronic Iron Deficiency as an Emerging Risk Factor for Osteoporosis: A Hypothesis · 2015
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.